About this trial
Consented patients will have three images taken of their dermatologic conditions within the Belle.ai software. These images will be uploaded and saved within the Belle software system where a single AI-generated differential list will be generated based on the three photos. All photos uploaded will be de-identified. The software will not have any unique identifiers of participants saved in the system. The photos will be named based on participant enrollment numbers or unique code numbers and no unique identifiers will be attached to the photos. There will be no data collection form necessary for this study
Eligibility criteria
Qualifiers
Patient must present to an Advocate Health dermatology clinic
Patient must have the ability and willingness to provide informed consent and comply with study procedures and visits
Participant dermatologists must have access to the required technology (e.g., smartphone with internet access) and be capable of using it for the required image capture
Disqualifiers
Patients who are unable to comply with study procedures due to physical or mental health limitations (as assessed by study coordinator)
Pediatric, adolescent, and teen patients who present with dermatological conditions on their genitalia will not be included in the study (in support of patient privacy concerns).
Trial design
Treatments tested in this trial
- Not listed
Trial groups
Sponsors and collaborators
Wake Forest University Health Sciences
Lead sponsor
BelleTorus Corporation
Collaborator